Soleus Capital Management as of Sept. 30, 2021
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 72 positions in its portfolio as reported in the September 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Bioatla (BCAB) | 11.5 | $74M | 2.5M | 29.44 | |
C4 Therapeutics Com Stk (CCCC) | 5.2 | $34M | 751k | 44.68 | |
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 4.9 | $32M | 1.2M | 25.68 | |
Dice Therapeutics | 4.5 | $29M | 880k | 32.75 | |
Theratechnologies | 4.4 | $29M | 7.6M | 3.75 | |
Neuropace (NPCE) | 4.1 | $27M | 1.7M | 15.85 | |
Essa Pharma Com New (EPIX) | 3.6 | $23M | 2.9M | 8.00 | |
SurModics (SRDX) | 3.3 | $21M | 382k | 55.60 | |
Astrazeneca Sponsored Adr (AZN) | 3.0 | $19M | 319k | 60.06 | |
Edap Tms S A Sponsored Adr (EDAP) | 2.9 | $19M | 3.0M | 6.38 | |
United Therapeutics Corporation (UTHR) | 2.9 | $19M | 102k | 184.58 | |
Iveric Bio | 2.8 | $18M | 1.1M | 16.24 | |
Natera (NTRA) | 2.4 | $16M | 139k | 111.44 | |
Iradimed (IRMD) | 2.4 | $15M | 451k | 33.59 | |
Sientra | 2.1 | $14M | 2.4M | 5.73 | |
Flexion Therapeutics | 2.0 | $13M | 2.1M | 6.10 | |
Enanta Pharmaceuticals (ENTA) | 1.6 | $10M | 182k | 56.81 | |
Crispr Therapeutics Namen Akt (CRSP) | 1.6 | $10M | 92k | 111.94 | |
CVRX (CVRX) | 1.6 | $10M | 619k | 16.54 | |
Werewolf Therapeutics (HOWL) | 1.5 | $9.7M | 563k | 17.16 | |
Neogenomics Com New (NEO) | 1.4 | $9.2M | 191k | 48.24 | |
Organogenesis Hldgs (ORGO) | 1.4 | $9.1M | 640k | 14.24 | |
Vaxcyte (PCVX) | 1.4 | $9.0M | 356k | 25.37 | |
Gossamer Bio Note 5.000% 6/0 (Principal) | 1.3 | $8.4M | 8.2M | 1.03 | |
Caredx (CDNA) | 1.3 | $8.0M | 127k | 63.37 | |
Nurix Therapeutics (NRIX) | 1.2 | $7.9M | 264k | 29.96 | |
Y Mabs Therapeutics (YMAB) | 1.2 | $7.6M | 266k | 28.54 | |
Inspire Med Sys (INSP) | 1.1 | $7.2M | 31k | 232.89 | |
Krystal Biotech (KRYS) | 1.0 | $6.6M | 126k | 52.21 | |
Cytosorbents Corp Com New (CTSO) | 1.0 | $6.5M | 800k | 8.12 | |
AngioDynamics (ANGO) | 1.0 | $6.3M | 243k | 25.94 | |
Galapagos Nv Spon Adr (GLPG) | 0.9 | $6.1M | 115k | 52.61 | |
Itamar Med Sponsored Ads | 0.9 | $5.5M | 181k | 30.22 | |
The Beauty Health Company Com Cl A (SKIN) | 0.8 | $5.2M | 202k | 25.97 | |
Somalogic Class A Com | 0.8 | $5.2M | 422k | 12.39 | |
Vanda Pharmaceuticals (VNDA) | 0.8 | $5.1M | 299k | 17.14 | |
Travere Therapeutics (TVTX) | 0.8 | $5.1M | 211k | 24.25 | |
Evolus (EOLS) | 0.8 | $4.9M | 643k | 7.62 | |
Atea Pharmaceuticals (AVIR) | 0.6 | $4.1M | 118k | 35.06 | |
Assembly Biosciences | 0.6 | $3.9M | 1.1M | 3.48 | |
Pieris Pharmaceuticals | 0.6 | $3.8M | 740k | 5.17 | |
Compass Pathways Sponsored Ads (CMPS) | 0.6 | $3.8M | 128k | 29.87 | |
Pacira Pharmaceuticals (PCRX) | 0.6 | $3.7M | 66k | 56.00 | |
Da32 Life Scnce Tec Acqstn C Class A Com | 0.5 | $3.4M | 350k | 9.83 | |
Arena Pharmaceuticals Com New | 0.5 | $3.4M | 57k | 59.54 | |
Xenon Pharmaceuticals (XENE) | 0.5 | $3.3M | 216k | 15.28 | |
Inhibrx | 0.5 | $3.3M | 98k | 33.31 | |
4d Molecular Therapeutics In (FDMT) | 0.5 | $3.3M | 121k | 26.97 | |
Novocure Ord Shs (NVCR) | 0.5 | $3.2M | 27k | 116.19 | |
Pulmonx Corp (LUNG) | 0.5 | $3.2M | 88k | 35.98 | |
Meridian Bioscience | 0.5 | $3.1M | 163k | 19.24 | |
Corcept Therapeutics Incorporated (CORT) | 0.5 | $3.0M | 155k | 19.68 | |
Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.5 | $3.0M | 300k | 10.05 | |
Peregrine Pharmaceuticals (CDMO) | 0.5 | $2.9M | 135k | 21.57 | |
Dyne Therapeutics (DYN) | 0.5 | $2.9M | 178k | 16.24 | |
Bridgebio Pharma Note 2.500% 3/1 (Principal) | 0.4 | $2.7M | 2.0M | 1.40 | |
Zogenix Com New | 0.4 | $2.6M | 171k | 15.19 | |
Axogen (AXGN) | 0.4 | $2.5M | 158k | 15.80 | |
Lyra Therapeutics (LYRA) | 0.3 | $2.0M | 216k | 9.12 | |
Celcuity (CELC) | 0.2 | $1.5M | 84k | 18.00 | |
Eiger Biopharmaceuticals | 0.2 | $1.4M | 214k | 6.68 | |
Bioventus Com Cl A (BVS) | 0.2 | $1.3M | 95k | 14.16 | |
Cytomx Therapeutics (CTMX) | 0.2 | $1.3M | 261k | 5.09 | |
Astria Therapeutics (ATXS) | 0.2 | $994k | 113k | 8.84 | |
Editas Medicine (EDIT) | 0.2 | $965k | 24k | 41.06 | |
Ngm Biopharmaceuticals | 0.1 | $862k | 41k | 21.02 | |
Procept Biorobotics Corp (PRCT) | 0.1 | $763k | 20k | 38.15 | |
Cutera (CUTR) | 0.1 | $675k | 15k | 46.62 | |
Beam Therapeutics (BEAM) | 0.1 | $670k | 7.7k | 87.01 | |
Rafael Hldgs Com Cl B (RFL) | 0.1 | $668k | 22k | 30.72 | |
Monte Rosa Therapeutics (GLUE) | 0.1 | $557k | 25k | 22.28 | |
Edgewise Therapeutics (EWTX) | 0.1 | $520k | 31k | 16.61 |